How many investments has Schooner Capital made?

Schooner Capital has 37 tracked investments, 4 of which have exited, including 6 dated in the last 24 months.

What stage does Schooner Capital invest at?

Schooner Capital invests at the Seed, Late Stage stages.

What sectors does Schooner Capital focus on?

Schooner Capital focuses on Sector Agnostic.

Where is Schooner Capital located?

Schooner Capital is headquartered in Boston, US.

Does Schooner Capital lead rounds?

Schooner Capital has led 5 of the 10 rounds where its role is on record.

Who does Schooner Capital co-invest with?

Schooner Capital most often shares deals with 20/20 HealthCare Partners LLC, Lifeforce Capital, Collaborative Fund, among 85 tracked co-investors.

What size deals does Schooner Capital back?

Across 7 deals with disclosed amounts, Schooner Capital has joined rounds of $6.5M – $50M (median $10M).

Schooner Capital

Crossover fund

Boston · Seed–Late Stage · 16 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Schooner Capital

2,820 people in our graph share verified history with the Schooner Capital team — schools, employers, funds. One of them is your warm intro.

Adam Valkinunlockedknows Peter Binas · together at Harvard University (overlapped)

×4knows the team · via Harvard Business School

×2knows the team · via McKinsey & Company

×3knows the team · via Goldman Sachs

knows the team · via MIT Sloan School of Management

knows the team · via Milton Academy

✨ Fox Verdict

Investment thesis

Schooner Capital operates from a permanent, evergreen capital base, investing in both private companies and public securities. It looks across sector, stage and geography, emphasizing independent judgment and contrarian thinking. With a patient approach developed over 55 years, the firm often invests multiple times in its holdings and favors deep, long-term partnerships with strong teams. Its evergreen structure and entrepreneurial roots let it respond to opportunities without mandate constraints or fundraising pressures. Profits support The Schooner Foundation, which is engaged in human rights causes globally.

Invests inSector AgnosticBoston Global

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Boston, US

Instruments

Equity

Founded

1971

Last 12 months

4 investments

Tracked investments

IPOs

Acquisitions

Team · 16 people

from the firm's website

Julia Pettengill· Executive Director of the Schooner Foundation· Boston, Massachusetts, United Statesin

Julia Pettengill is Executive Director of the Schooner Foundation, where she directs global grantmaking and operations across more than eighty partnerships in areas including human rights, global health equity, mental health, education, and environmental resilience. She has developed and managed philanthropic funds such as the Foundation's crisis response fund and global mental health portfolio. She holds a Bachelor of Arts and a Master of Education from the University of Cape Town.

Vin Ryan· Founder and Chairman

Vin Ryan founded Schooner in 1971 and has led the firm for over five decades. He purchased and grew Iron Mountain, a global records management company, serving as its director from 1971 to 2015, and was a director and investor in Continental Cablevision for more than two decades until its 1996 sale. He also founded National Hydro and Arch Mobile Communications, established The Schooner Foundation in 1996, and is a graduate of Boston University.

Alexandra Manick· Managing Director· Boston, Massachusetts, United Statesin

Alex Manick is a Managing Director at Schooner Capital who works on venture and growth investments. She holds a BS in Materials Science from MIT and an MBA from Stanford, and earlier worked at MIT spin-out 1366 Technologies. She currently sits on the boards of several portfolio companies and previously served as a director at Jetcool Technologies before its acquisition by Flex.

Antonio Cienfuegos· Managing Director· Greater Bostonin

Antonio Cienfuegos joined Schooner Capital in 2014 and serves as a Managing Director focused on the firm's direct public equity investment efforts, which he helped launch and manage. He works on investment identification, due diligence, valuation, portfolio construction and trading for the public equities portfolio across US and global markets, and also provides corporate finance and strategic support across the broader portfolio. He holds dual degrees in Financial Economics and Hispanic Studies from Columbia University.

Brian Rodgers· Controller· Wenham, Massachusetts, United Statesin

Brian Rodgers joined Schooner Capital in 2010 and became its Controller in 2023, where he works on internal financial matters and tax preparation. Before Schooner, he spent three years in public accounting at Tonneson & Company CPA's P.C. handling attestation and tax engagements. He holds an undergraduate degree and a Master's of Accounting from the University of New Hampshire and is a licensed CPA in Massachusetts.

Carl Becker· Associate· Boston, Massachusetts, United Statesin

Carl Albrecht Becker is an Associate at Schooner Capital working on venture and growth investments. Before joining the firm, he was a Consultant at Bain & Company and held roles at startups and larger companies including Volkswagen and Deutsche Telekom. He earned a BSc and MSc in Business Administration and Electrical Power Engineering from RWTH Aachen University and an MBA from MIT Sloan.

Chan Won· Analyst· Boston, Massachusetts, United Statesin

Chan Won is an Analyst at Schooner Capital working on public equity investment opportunities, supporting the process from idea generation through diligence, valuation, and execution, as well as portfolio monitoring. He joined the firm after graduating from New York University with dual degrees in Finance and Data Science. Before Schooner, he was the sole analyst at a consumer-focused public equity fund and a summer associate in Temasek's investment group.

Isabel Vinson· Operations Associate· Boston, Massachusetts, United Statesin

Isabel Vinson is an Operations Associate at Schooner Capital and the Schooner Foundation, where she oversees day-to-day operations and serves as the firm's benefits administrator. At the foundation, she works with the Executive Director on the internship program, communications, and operations. She holds a Bachelor of Arts in Political Science and French, with minors in Criminal Justice and European Studies, from the University of Wisconsin-Madison.

Jon Corbett· Managing Director and Chief Financial Officer· Boston, Massachusetts, United Statesin

Jon Corbett is Managing Director and CFO of Schooner Capital, named to the CFO role in 2024 after serving as VP Finance from 2018 and Controller from 2011. He oversees Schooner's accounting, finance operations, and tax compliance, supports its public equities efforts, and works with several private portfolio companies, including a directorship at SRS Medical. Before Schooner, he spent over a decade in public accounting at Tonneson + Co, holds a business degree from Merrimack College and a Master of Science in Taxation from Bentley University, and is a CPA in Massachusetts.

Laurie Finkielsztein· Senior Associate· United Statesin

Laurie Finkielsztein is a Senior Associate at Schooner Capital, working on early and growth stage investments. Before Schooner, she was on the investment team at Fifth Wall and started her career in investment banking within the TMT group at Goldman Sachs. She holds a degree in Computer Science from Brown University.

Lou Stathis· Staff Accountant

Lou Stathis joined Schooner Capital in 2005 as a staff accountant, handling accounts receivable, accounts payable, general ledger, and payroll. He previously worked as an accountant for the Boston Red Sox Baseball Club. He holds a degree from the University of Massachusetts' School of Management with a concentration in accounting.

Orhan Gazelle· Managing Director· Boston, Massachusetts, United Statesin

Orhan Gazelle is a Managing Director at Schooner Capital, where he works on early and growth stage investments. He has held board roles at several SaaS companies and other firm holdings. He earned a Master of Engineering Management from Dartmouth College's Thayer School of Engineering and a BS with Honors in Mechanical Engineering from Trinity College.

Peter Binas· Chief Investment Officer, Managing Partner· United Statesin

Peter Binas is Schooner Capital's Chief Investment Officer and a Managing Partner, where he leads the firm's global direct public equity investing program and has worked across its private and public investing efforts for over fifteen years, including helping the firm return to direct investing. Before joining Schooner, he spent nearly ten years at McKinsey & Company. He holds a joint JD/MBA from Harvard Law School and Harvard Business School, where he was a Baker scholar, and earned an AB in Economics and Social Studies from Harvard University.

Rachel Billings· Austin, Texas, United Statesin

Rachel Billings joined Schooner Capital in 2011 as executive assistant to the chairman and oversaw the Foundation from 2013 to 2018. Before that, she worked as a legislative specialist at InstaTrac, a Massachusetts legislation tracking web service. She attended the University of Massachusetts Amherst.

Solita Im· Accounting and Tax Manager· Toronto, Ontario, Canadain

Solita Im is an Accounting and Tax Manager at Schooner Capital, where she handles internal accounting, tax compliance, and reporting. Before joining the firm, she spent more than nine years in public accounting at Tonneson & Company and PricewaterhouseCoopers, working on tax matters for clients including high-net-worth individuals, partnerships, trusts, and private foundations. She earned a B.S. in Corporate Finance & Accounting and an M.S. in Taxation from Bentley University and is a CPA licensed in Massachusetts.

Ted Henderson· Chief Executive Officer, Managing Partner

Ted Henderson is Chief Executive Officer and a Managing Partner at Schooner Capital, where he focuses on internal management and firm strategy and has led the firm's return to direct investing over several decades, primarily in venture-stage companies. He serves as a director at Brixton Biosciences and SRS Medical. He holds an MBA from Harvard Business School and graduated cum laude from Dartmouth College, where he studied Mandarin.

What they invest in

from 33 of 37 portfolio companies

SaaS ×13AI & Machine Learning ×8Biotech ×8Healthtech ×8Enterprise Software ×6Deep Tech ×5Cloud Computing ×4Digital Health ×4

HQs:United States×20Australia×1Canada×1United Kingdom×1Ireland×1

Who they back

founder profiles across 16 portfolio companies

56%

solo founders

9 of 16 mapped founding teams

35%

repeat founders

of 17 founders with career history

Founding team size:solo founder×92 founders×33 founders×34+ founders×1

Where their founders studiedfrom 17 founders with education data

Massachusetts Institute of Technology ×4Technical University of Munich ×2

What their founders studiedfrom 16 founders with field-of-study data

Engineering ×8Business & Management ×2Chemistry ×2Computer Science ×2Economics ×2Life Sciences ×2

Where their founders worked beforefrom 17 founders with career history

Carnegie Mellon University ×2

Investments · 37 tracked

founders shown can be your intro path

By year:2026 · 4 2025 · 2 2024 · 1 2023 · 3 2022 · 2 2020 · 113 dated

Cartesian Therapeutics (NASDAQ: RNAC)cartesiantherapeutics.com in 𝕏NASDAQ: RNAC

Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies aimed at treating autoimmune diseases.

BiotechHealthtechWatertown, US

Metin Kurtoglu(Executive Officer)Omid Farokhzad(Director)Chris Jewell(Executive Officer)in Carsten Brunn(President, CEO & Chairman of the Board)inEmily English(Executive Officer)in Blaine Davis(Executive Officer)in

Co-investorsK2 HealthVentures Maryland TEDCO TEDCO +ND Capital Polaris Partners RUSNANO

4G Clinical4gclinical.com in

4G Clinical builds randomization and trial supply management (RTSM) technology for complex clinical trials, serving biotech, biopharma, and CRO sponsors.

BiotechDigital HealthSaaSDover, US

Edward Tourtellotte(Executive Officer)David Kelleher(CEO)in

Co-investorsGoldman Sachs

Amplifiedamplified.co in 𝕏

Amplified helps brands and advertisers measure and optimize the value of consumer attention through data-driven tools and insights.

AdTechAI & Machine LearningData & InfrastructureMarketing TechSaaSAdelaide, AU

Co-investorsTen13 Elevate Ventures

Amplified Industriesamplified.industries in 𝕏Mar 2025

Amplified Industries builds wireless sensors and an AI-driven platform for monitoring and optimizing oilfield assets, offering well data capture, pump diagnostics (DynaCard/PumpCard), remote pump-off control, and spill and leak prevention.

AI & Machine LearningEnergyIoTBoston, US

Sebastien Mannai(Executive Officer, Director)inCharles-Henri Clerget(Executive Officer, Director, Promoter)

BoardWilliam Severns(Director)Alexandra Manick(Director)in

Co-investorsArgon Ventures SBXi

Bentobento.net in 𝕏Jul 2022 · $8M

Bento operates a dental benefits platform that lets employers, associations, and health plans offer self-insured, customizable dental and vision plans with transparent pricing and AI-enabled real-time claim adjudication.

HealthtechInsurTechSaaS

Ram Sudireddy(CEO & Founder)in

Co-investorsCompanyon Ventures York IE

Bestdoctorsbestdoctors.com in 𝕏acquired by Teladoc Health

Digital HealthHealthtechMental Health

Breezewaybreezeway.ioMar 2026

AI-driven task management software for property managers

Boston, US

Jeremiah Gall(Executive Officer, Director)Jeremy Gall(Founder)in

Board Ed Walters(Director)Jeremiah Doyle(Director)Orhan Gazelle(Director)inSimon Lehmann(Director)

Co-investorsCatalyst Investors Krillion Ventures LaunchCapital Tamarisc Ventures

Brixtonbiobrixtonbio.com

Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration.

BiotechMedical Devices

Charles Sidoti(Founder)in

Co-investorsAngel Physicians Fund Excelestar Ventures FemHealth Ventures SV Health Investors

Capitalprovisionscapitalprovisions.com

Capital Provisions provides office break room and unattended retail services including vending machines, micro markets, coffee, water, and pantry service, using logistics and inventory management technology.

FoodTechLogistics & Supply ChainRetail Tech

Carecubescarecubes.com inMar 2026 · $6.5M

Carecubes provides healthcare facilities with solutions to prevent infectious disease spread while maintaining patient connections to family members.

HardwareHealthtechMedical Devices

Co-investorsLifeforce Capital Very Serious Ventures

Censinetcensinet.com inJan 2023 · $9M

Censinet provides risk management solutions for healthcare organizations, built by former healthcare operators and security experts who understand the integrated risks healthcare systems face.

CybersecurityEnterprise SoftwareHealthtechSaaSBoston, US

Ed Gaudet(Founder)inCambrey Warein

Co-investorsBallad Ventures Excelerate Health Ventures HLM Venture Partners MemorialCare Innovation Fund Excel Venture Management LRVHealth +1 more

Commonwealth Fusion Systemscfs.energy in 𝕏May 2020 · $84M

Commonwealth Fusion Systems develops commercial fusion power plants using high-temperature superconducting magnet technology to provide grid-scale energy.

CleantechClimate TechDeep TechEnergyCambridge, US

Brandon Sorbom(Founder)inRobert Mumgaard(Executive Officer, Director)in Daniel Brunner(Executive Officer)in Bob Mumgaard(Founder)in

BoardMassimiliano Pieri(Director)Katie Rae(Director)in

Co-investorsAdvection Growth Capital Armada Investment AG Bay Bridge Ventures Climate Beni Venture Capital Brainstorm Ventures Breakthrough Energy Ventures +39 more

Congruity360congruity360.com in

Congruity360 provides unstructured data management and governance software for enterprises managing large, dispersed datasets across multiple storage systems.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareFall River, US

Co-investorsFlow Capital G20 Ventures

Crunchtimecrunchtime.com inAug 2026 · $80M

Crunchtime provides restaurant operations management software for multi-unit and enterprise restaurant brands, covering inventory management, labor and scheduling, operations execution, learning and development, and kitchen management.

AI & Machine LearningEnterprise SoftwareFoodTechSaaSSan Francisco, US

Co-investorsBattery Ventures Golub Growth DERIVE VENTURES Osage Venture Partners Ten Coves Capital

Cullinan Oncologycullinanoncology.com in 𝕏

Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.

BiotechDigital Health

Co-investorsLAV Lilly Asia Ventures MPM BioImpact Taiho Ventures, LLC

CustomMadecustommade.com 𝕏

CustomMade is a custom jewelry design and creation service that works with clients to create bespoke pieces, including bridal, heirloom redesign, and fine jewelry.

B2B MarketplacesConsumerDirect to ConsumerE-commerceDover, US

Seth Rosen(Executive Officer, Director)in

BoardDavid Hauser(Director)Sasha Shusteff(Director)

Co-investorsAtlas Venture First Round Capital Founder Collective GV (Google Ventures)Launch Capital NextView Ventures

Emerald Cloud Labemeraldcloudlab.com in

Emerald Cloud Lab (ECL) provides remote, cloud-based access to a life science research laboratory, letting researchers run and automate experiments and workflows without a physical lab.

BiotechCloud ComputingDeep TechAustin, US

Brian Frezza(Founder)inD.J. Kleinbaum(Founder)in

Co-investorsBlue Ivy Ventures Gigafund Soundproof Ventures Founders Fund OS Fund

JetCooljetcool.com in 𝕏Oct 2023 · $17M

JetCool designs direct-to-chip liquid cooling modules that use microconvective cooling technology to reduce energy consumption, water usage, and carbon footprints in high-power electronics.

CleantechDeep TechHardwareSemiconductorsLittleton, US

Bernard Malouin Jr.(Executive Officer, Director)Jordan Mizerak(Cofounder)in Bernie Malouin(Founder & CEO)in Alexandra Manick(Director)inLawrence Fish(Director)

Co-investorsBosch Ventures MassVentures Robert Bosch Venture Capital In-Q-Tel Raptor Group

Kewazokewazo.com in

KewaZo builds construction automation technology, including robotic systems for material transport at industrial and construction sites, aimed at reducing crane time and improving safety.

Construction TechHardwareRobotics

Ekaterina Grib(Founder)in Artem Kuchukov(Founder)inLeonidas Pozikidis(Founder)in

Co-investorsBenson Capital Chevron Technology Ventures Cybernetix Ventures Fifth Wall Gaingels Mana Ventures +1 more

Kythera Biopharmaceuticalsallergan.comAcquired

Aesthetic-medicine biopharma behind KYBELLA (deoxycholic acid) injection, acquired by Allergan in 2015 for ~$2.1 billion.

Co-investorsAisling Capital ARCH Venture Partners Prospect Venture Partners ALTITUDE LIFE SCIENCE VENTURES Foley Ventures Invus

Mannamanna.aeroApr 2026 · $50M

Manna operates an air delivery service using drone technology to deliver medical equipment, food, and other goods, with plans to reduce traffic and improve air quality in urban areas.

Deep TechLogistics & Supply ChainMobility & Transportation

Bobby Healy(Founder)in

Co-investorsAtlantic Bridge Ventures Ff Venture Capital Frontline Ventures Molten Ventures Radius Capital Ventures Tapestry VC +1 more

Mantleheymantle.comJul 2024 · $20M

Mantle provides a business operations platform for app developers and businesses, offering billing, payment pages, analytics, email marketing, and integrations with tools like Stripe and Shopify.

Creator EconomyFintechSaaS

Co-investorsKillick Capital OpenSky Ventures 11.2 Capital Corazon Capital Craft Ventures Foundation Capital +2 more

MarginEdgemarginedge.com in 𝕏

MarginEdge builds a restaurant management platform that handles invoice processing, inventory, cost tracking, and accounting integrations for restaurant operators.

FintechFoodTechSaaSArlington, US

Roy Phillips(Co-founder, Client Services)inBo Davis(Co-founder & CEO)in Brian Mills(Co-founder & CTO)inEmma Whelan(Chief Financial Officer)inJess Finnefrock(Chief Operating Officer)inTara Clever(Chief Revenue Officer)in

Co-investorsBranded Strategic Hospitality Connetic Ventures DERIVE VENTURES IrishAngels Osage Venture Partners Ten Coves Capital

Mediasilomediasilo.com in 𝕏

MediaSilo is a cloud-based platform for managing, reviewing, and distributing video production assets securely.

Cloud ComputingEnterprise SoftwareMedia & EntertainmentSaaS

PartnerTed Henderson· led

Meilimeili.travel

Meili is a direct ancillary distribution platform that enables airlines and travel brands to offer car rental, hotel and mobility products to travelers.

B2B MarketplacesMobility & TransportationSaaSTravel & Hospitality

Mimetogenmimetogen.com

Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease.

BiotechMedical DevicesMontreal, CA

Dr. Brazzell(Chief Medical Officer)François Mongrain(Chief Executive and Financial Officer)inKaren Meerovitch(Sr Vice-President and Chief Development Officer)in

BoardKevin Giese(Executive Chairman of the Board)Steven A. Pepose(Chief Medical Advisor)

Onebeatonebeat.co in 𝕏May 2025 · $15M

Onebeat provides AI-powered software that optimizes retail inventory management across the product lifecycle, helping retailers forecast demand, allocate stock, and replenish inventory in real time to increase full-price sales and reduce waste.

AI & Machine LearningRetail TechSaaS

Dr Yishai Ashlag(CEO)inAvihai Shnabel(CBO)inLena Vatmacher(CHRO)inDima Dobrinsky(CTO)in

Co-investorsAnD Ventures Magenta Venture Partners Surround Ventures

Ottometricottometric.com in 𝕏Jan 2023 · $10M

Ottometric provides a cloud-based data platform for developing driver-assistance and autonomous vehicle systems, automating validation workflows and transforming test data into actionable insights for automotive OEMs and suppliers.

AI & Machine LearningData & InfrastructureSaaSWaltham, US

John Curran(Executive Officer)Joseph Burke(Executive Officer, Director)inNick Pandher(Executive Officer)

Board Orhan Gazelle(Director)inRich Redelfs(Director)in Zenas Hutcheson(Director)in

Co-investorsRally Ventures Management, Llc Huntington Angels Network Proeza Ventures PS27 Ventures Trucks VC Somersault Ventures

Railcommrailcomm.com in 𝕏

Tracsis provides computer-aided dispatching solutions for railroad operations, including train control platforms and traffic management systems designed to reduce human error and optimize resource efficiency.

AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainMobility & TransportationSaaS

PartnerPeter Binas· led

Remedy Planremedyplan.com in

Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer.

BiotechHealthtechRockville, US

Gregory Plan Crimmins(Executive Officer, Director)

Co-investors20/20 HealthCare Partners LLC Alexandria

Seventhgenerationseventhgeneration.com in

Seventh Generation manufactures plant-based household and personal care products designed to reduce environmental impact and promote sustainable practices.

Circular EconomyCleantechClimate TechConsumerImpact & Social Good

Jeffrey Hollender(Founder)in

Co-investorsRenewal Funds

Spottedriskspottedrisk.com in

SpottedRisk offers insurance, bonding, and lending products tailored to the film and television production industry, working with producers and production companies.

FintechInsurTechMedia & Entertainment

Co-investorsBantam Group

Srsmedicalsrsmedical.com

SRS Medical develops diagnostic and therapeutic technologies for urologic care, specifically for men with Benign Prostate Hyperplasia, using bladder function assessment to guide clinical treatment decisions.

Digital HealthHealthtechMedical Devices

Lee Brody(Chief Executive Officer)Chris Ernster(Vice President of Sales & Marketing)David Mahoney(EVP of New Business Development)

Wavebreaktxwavebreaktx.com in

Wavebreak develops a drug discovery platform targeting amyloid oligomers, toxic protein intermediates implicated in neurodegenerative diseases including Alzheimer's and Parkinson's.

AI & Machine LearningBiotechDeep TechHealthtech

Bart Henderson(President & Chief Executive Officer)in

Co-investorsLifeforce Capital

Zixizixi.com in 𝕏acquired by Clearhaven Partners

Zixi provides software solutions for broadcast and live video workflows, serving content owners, broadcasters, service providers, sports organizations, and OTT providers with capabilities for content contribution, satellite replacement, B2B distribution, and direct-to-consumer enablement.

Cloud ComputingEnterprise SoftwareMedia & EntertainmentSaaS

Uri Avni(Co-Founder, CTO)

PartnerTed Henderson· led

Co-investors20/20 HealthCare Partners LLC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

MillstonemedicalZippity

Exits · 4

1 IPOs · 3 acquisitions · showing 3

Cartesian Therapeutics (NASDAQ: RNAC)NASDAQ: RNACBestdoctorsacq. by Teladoc HealthZixiacq. by Clearhaven Partners

Portfolio news

latest coverage across their companies

MarginEdge Raises $80 Million Series D As Platform Processes $28 Billion In Restaurant Purchasing

MarginEdge · pulse2.com · Aug 21, 2026

MarginEdge Raises $80 Million as Competition for the AI-Powered Restaurant Back Office Intensifies |

Crunchtime · restauranttechnologynews.com · Aug 13, 2026

Scoop: Goldman-backed 4G Clinical on the block

4G Clinical · axios.com · Aug 13, 2026

Fusion power darling Commonwealth Fusion Systems raises another $1B

Commonwealth Fusion Systems · techcrunch.com · Jul 30, 2026

Hunt Energy's Dallas-Based Subsidiary Mantle Energy Raises $5M Seed Funding » Dallas Innovates

Mantle · dallasinnovates.com · Jun 24, 2026

Cullinan Oncology stock hits 52-week high at $17.97 By Investing.com

Cullinan Oncology · investing.com · Jun 23, 2026

Data center liquid cooling startup JetCool raises $17m - DCD

JetCool · datacenterdynamics.com · Jun 18, 2026

Carecubes Appoints New CEO Following Series A Funding and Market Expansion - TipRanks.com

Carecubes · tipranks.com · Jun 3, 2026

Frequently asked questions

How many investments has Schooner Capital made?: Schooner Capital has 37 tracked investments, 4 of which have exited, including 6 dated in the last 24 months.
What stage does Schooner Capital invest at?: Schooner Capital invests at the Seed, Late Stage stages.
What sectors does Schooner Capital focus on?: Schooner Capital focuses on Sector Agnostic.
Where is Schooner Capital located?: Schooner Capital is headquartered in Boston, US.
Does Schooner Capital lead rounds?: Schooner Capital has led 5 of the 10 rounds where its role is on record.
Who does Schooner Capital co-invest with?: Schooner Capital most often shares deals with 20/20 HealthCare Partners LLC, Lifeforce Capital, Collaborative Fund, among 85 tracked co-investors.
What size deals does Schooner Capital back?: Across 7 deals with disclosed amounts, Schooner Capital has joined rounds of $6.5M – $50M (median $10M).

Similar investors

83North

83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.

$100K – $10M

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50M

Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

$1.6M – $70M

AirTree Ventures

AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.

$132K – $16.5M

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

$500K – $50M